Literature DB >> 62971

Agranulocytosis and aprindine.

R van Leeuwen, R H Meyboom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 62971     DOI： 10.1016/s0140-6736(76)91116-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  New strategies for drug monitoring.

Authors:  R H Meyboom
Journal:  Br Med J       Date:  1977-06-25

Review 2.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

Review 3.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

4.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

Review 5.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

6.  Moxaprindine in the acute treatment of ventricular arrhythmias in patients with cardiovascular disease.

Authors:  J Staessen; H Kesteloot
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

7.  Effects on rabbit cardiac potentials of aprindine and indecainide, a new antiarrhythmic agent, in normoxia and hypoxia.

Authors:  P D Dennis; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.